Association Between Risk of Clostridium difficile Infection and Duration of Proton Pump Inhibitor or H2-Receptor Antagonist Use in Hospitalized Patients

Association Between Risk of Clostridium difficile Infection and Duration of Proton Pump Inhibitor or H2-Receptor Antagonist Use in Hospitalized Patients

Abstract Introduction Limited studies have evaluated the association between Clostridium difficile infection (CDI) and the duration of proton pump inhibitor (PPI) or histamine H2-receptor blocker (H2RA) use and provided a cutoff duration for PPI or H2RA use to mitigate a substantially increased risk...

Full description

Bibliographic Details
Main Authors: Chien-Huei Huang, Yung-Hsin Tseng, Wen-Shan Tsai, Chien-Chou Su, Ching-Lan Cheng, Yea-Huei Kao Yang, Yu-Ching Chang, Yi-Hsuan Liu
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-01-01
Series:Infectious Diseases and Therapy
Subjects:
Clostridium difficile infection
Histamine H2-receptor blocker
Pharmacoepidemiology
Proton pump inhibitor
Online Access:https://doi.org/10.1007/s40121-024-00922-5

Internet

https://doi.org/10.1007/s40121-024-00922-5

Similar Items